DailyIQ
|
Sector:Consumer DefensiveAll sectors
Last updated 2 minutes ago

PM·Philip Morris International Inc.

$.
+. (+.%)
After Hours
High
$194.62
Open
$191.99
Market Cap
293.77B
52W High
$193.05
Low
$189.89
P. Close
$189.83
P/E
26.48
52W Low
$142.11
Fwd P/E
94.22
DailyIQ Est.
$198.32
Technical Score (1D)
100
BUY
News Sentiment
67
BULLISH
Philip Morris International’s webcast on July 22 at 7:00 a.m. ET will release its Q2 and first‑half results and provide management commentary, making it the primary catalyst for the next 1–10 trading days. The earnings announcement will determine whether the company’s smoke‑free momentum and pricing power translate into a beat or miss, a key driver for short‑term price action. Analysts are split: some forecast a miss due to missing key drivers, while others project a beat driven by higher pricing power in core markets and a potential dividend lift, creating uncertainty that traders must navigate. This split outlook underscores the importance of watching the guidance released during the webcast for clues on future margins and smoke‑free growth. UBS’s recent lift of the price target to $182, citing the shift to high‑margin smoke‑free products, signals that the market is pricing in a favorable trajectory for the portfolio and that valuation multiples may tighten if earnings confirm upside. That upgrade also highlights the significance of the FDA’s first modified‑risk authorization for 20 ZYN variants, which could broaden the product’s U.S. market share and strengthen PM’s earnings mix. The technical breakout setup, with an 8/10 rating and consolidation near resistance, suggests a momentum play that could be activated if the earnings release confirms upside expectations. Traders should monitor post‑earnings analyst revisions and any updates on regulatory approvals for nicotine pouches, as these will affect the valuation multiples and dividend outlook. In addition, keep an eye on consumer adoption data for ZYN and any competitor responses, as shifts in the smokeless market could alter PM’s competitive positioning over the next few weeks.
Earnings Summary
Philip Morris International (PM) is a global tobacco company headquartered in Stamford, Connecticut, that produces traditional cigarettes and a growing portfolio of smoke‑free products such as IQOS and ZYN. Operating in the consumer‑defensive tobacco sector, PM has positioned itself to navigate shifting consumer preferences toward lower‑risk nicotine delivery systems. In the most recent six quarters, PM has consistently outperformed earnings estimates, posting EPS beats in five of the last six periods while revenue has shown a mixed trajectory: a decline in Q1 2025 followed by consecutive gains in Q2 and Q3 2025, a dip in Q4 2025, and a rebound in Q1 2026. The company’s EPS growth accelerated from 1.55 in Q4 2024 to 2.24 in Q3 2025, then moderated to 1.70 in Q4 2025 before rising again to 1.96 in Q1 2026, indicating a pattern of strong profitability that occasionally lags revenue momentum. Historically, PM has maintained a steady YoY revenue growth of roughly 3–4% over the past three years, with EPS consistently beating analyst expectations except for the Q4 2025 miss, underscoring its pricing power and cost discipline. Recent news highlights a July 22 webcast that will release Q2 2026 results, with analysts split on whether the company will beat or miss expectations; the event is seen as a key catalyst for short‑term price action. The upgrade of PM’s price target by UBS to $182, citing the shift to high‑margin smoke‑free products, and the FDA’s authorization of 20 ZYN variants suggest regulatory momentum that could strengthen the earnings mix. Investors should watch the Q2 2026 earnings release for guidance on margin outlook, smoke‑free growth, and any dividend adjustment, as these factors will shape the company’s valuation trajectory in the coming quarter.

EPS

EstBeatMiss
$1.52$1.72$1.93$2.13$2.33Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.05 - -
Q1'26$1.83$1.96+7.1%
Q4'25$1.75$1.70-2.9%
Q3'25$2.10$2.24+6.9%
Q2'25$1.86$1.91+2.8%
Q1'25$1.61$1.69+4.8%

Revenue

EstBeatMiss
$9.1B$9.6B$10.1B$10.7B$11.2BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$11.0B - -
Q1'26$9.9B$10.1B+2.4%
Q4'25$10.8B$10.4B-3.6%
Q3'25 - $10.8B -
Q2'25 - $10.1B -
Q1'25 - $9.3B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

PM Stock Snapshot

PM is currently trading at $189.00, giving Philip Morris International Inc. a market cap of 293.77B and a P/E ratio of 26.5. Today's range spans $189.89–$194.62, with shares opening at $191.99 and moving down $0.83 (0.4%) from the prior close. DailyIQ's technical score sits at 100/100 (BUY) with a news sentiment reading of 67/100.

Over the past year PM has traded between $142.11 and $193.05 - the current price is +33.0% off the 52-week low and -2.1% from the high. 28 analysts cover the stock with a Buy consensus and a mean 12-month target of $194.86 (range $171.00–$210.00), implying upside of +3.1%.

What PM has right now - BUY signal, 100/100 technical score, bullish sentiment at 67/100, price $189.00 (near 52-week highs) - is the profile that shows up in screens looking for Consumer Defensive growth stories with technical confirmation. (P/E: 26.5) At 293.77B in capitalization, the risk/reward of a setup like this is often better than in mega-cap peers where the same signal translates to a smaller percentage move. Range: $142.11–$193.05.

Earnings revision cycles in large-cap Consumer Defensive names tend to compound: when technicals confirm a BUY thesis (100/100) and news sentiment (67/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $189.00 (near 52-week highs), PM's position within the $142.11–$193.05 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.